| Dr Justin E Hugo, MD | |
|
714 Gravois Rd, Suite 210, Fenton, MO 63026-7727 | |
| (314) 543-5230 | |
| (314) 543-5280 |
| Full Name | Dr Justin E Hugo |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 20 Years |
| Location | 714 Gravois Rd, Fenton, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104826098 | NPI | - | NPPES |
| 208987800 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2004002167 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital South | Saint louis, MO | Hospital |
| Mercy Hospital St Louis | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Multispecialty Group Inc | 1658365572 | 151 |
News Archive
Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $150,000 Phase I Grant from the National Science Foundation (NSF). This initial round of funding from NSF will enable Akonni to assess the feasibility of developing a lab-on-a-film microarray device that can be manufactured in a reel-to-reel format.
In a study in type 2 diabetic rats, researchers at the Karolinska Institutet have identified alterations in specific nerve cells that are important for odor identification. The findings might explain why type 2 diabetic patients often experience smelling problems and potentially open up a new research field to develop preventive therapies against neurodegenerative diseases in type 2 diabetic patients.
Smoking during pregnancy increases the risk for asthma and wheezing in early childhood, even if children are not exposed to smoke after birth, a European study shows.
ChemoCentryx, Inc., today announced that GlaxoSmithKline (GSK) has exercised its option to obtain an exclusive license for further development and worldwide commercialization of the investigational medicine CCX354, a potent and selective inhibitor of CCR1, a chemokine receptor that drives the recruitment of inflammatory cells into the joints of patients with rheumatoid arthritis (RA).
Hungry people are often difficult to deal with. A good meal can affect more than our mood, it can also influence our willingness to take risks. This phenomenon is also apparent across a very diverse range of species in the animal kingdom.
› Verified 6 days ago
| Entity Name | American Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972559532 PECOS PAC ID: 1658365572 Enrollment ID: O20040413001412 |
News Archive
Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $150,000 Phase I Grant from the National Science Foundation (NSF). This initial round of funding from NSF will enable Akonni to assess the feasibility of developing a lab-on-a-film microarray device that can be manufactured in a reel-to-reel format.
In a study in type 2 diabetic rats, researchers at the Karolinska Institutet have identified alterations in specific nerve cells that are important for odor identification. The findings might explain why type 2 diabetic patients often experience smelling problems and potentially open up a new research field to develop preventive therapies against neurodegenerative diseases in type 2 diabetic patients.
Smoking during pregnancy increases the risk for asthma and wheezing in early childhood, even if children are not exposed to smoke after birth, a European study shows.
ChemoCentryx, Inc., today announced that GlaxoSmithKline (GSK) has exercised its option to obtain an exclusive license for further development and worldwide commercialization of the investigational medicine CCX354, a potent and selective inhibitor of CCR1, a chemokine receptor that drives the recruitment of inflammatory cells into the joints of patients with rheumatoid arthritis (RA).
Hungry people are often difficult to deal with. A good meal can affect more than our mood, it can also influence our willingness to take risks. This phenomenon is also apparent across a very diverse range of species in the animal kingdom.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Justin E Hugo, MD 714 Gravois Rd, Suite 210, Fenton, MO 63026-7727 Ph: (314) 543-5230 | Dr Justin E Hugo, MD 714 Gravois Rd, Suite 210, Fenton, MO 63026-7727 Ph: (314) 543-5230 |
News Archive
Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $150,000 Phase I Grant from the National Science Foundation (NSF). This initial round of funding from NSF will enable Akonni to assess the feasibility of developing a lab-on-a-film microarray device that can be manufactured in a reel-to-reel format.
In a study in type 2 diabetic rats, researchers at the Karolinska Institutet have identified alterations in specific nerve cells that are important for odor identification. The findings might explain why type 2 diabetic patients often experience smelling problems and potentially open up a new research field to develop preventive therapies against neurodegenerative diseases in type 2 diabetic patients.
Smoking during pregnancy increases the risk for asthma and wheezing in early childhood, even if children are not exposed to smoke after birth, a European study shows.
ChemoCentryx, Inc., today announced that GlaxoSmithKline (GSK) has exercised its option to obtain an exclusive license for further development and worldwide commercialization of the investigational medicine CCX354, a potent and selective inhibitor of CCR1, a chemokine receptor that drives the recruitment of inflammatory cells into the joints of patients with rheumatoid arthritis (RA).
Hungry people are often difficult to deal with. A good meal can affect more than our mood, it can also influence our willingness to take risks. This phenomenon is also apparent across a very diverse range of species in the animal kingdom.
› Verified 6 days ago
Susan J. Davis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1345 Smizer Mill Rd Ste 1100, Fenton, MO 63026 Phone: 636-496-5023 | |
Sarah Ludlow, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1345 Smizer Mill Rd Ste 1100, Fenton, MO 63026 Phone: 636-496-5022 | |
Dr. John Martin Crowe Jr., M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1670 Fenpark Dr, Fenton, MO 63026 Phone: 636-492-6376 Fax: 636-326-6557 | |
Dr. Melissa Ann Muench, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 714 Gravois Rd Ste 210, Fenton, MO 63026 Phone: 636-660-9850 Fax: 636-660-9851 | |
Mr. Christopher Paul Friesen, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 320 Gravois Rd, Suite B, Fenton, MO 63026 Phone: 636-305-1899 Fax: 636-305-1898 | |
Brenda Lynn Buckley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1747 Smizer Station Rd, Suite 5, Fenton, MO 63026 Phone: 636-529-7000 Fax: 636-529-7003 |